Stock Analysis on Net

Cytokinetics Inc. (NASDAQ:CYTK)

This company has been moved to the archive! The financial data has not been updated since November 3, 2023.

Analysis of Liquidity Ratios 

Microsoft Excel

Liquidity Ratios (Summary)

Cytokinetics Inc., liquidity ratios

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Current ratio 9.40 7.45 15.20 8.98 9.36
Quick ratio 9.25 7.28 15.02 8.85 9.05
Cash ratio 9.25 6.56 14.87 8.65 8.95

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Cytokinetics Inc. current ratio deteriorated from 2020 to 2021 but then slightly improved from 2021 to 2022.
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Cytokinetics Inc. quick ratio deteriorated from 2020 to 2021 but then slightly improved from 2021 to 2022.
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Cytokinetics Inc. cash ratio deteriorated from 2020 to 2021 but then slightly improved from 2021 to 2022.

Current Ratio

Cytokinetics Inc., current ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in thousands)
Current assets 795,186 535,672 474,221 233,752 207,674
Current liabilities 84,617 71,860 31,199 26,023 22,194
Liquidity Ratio
Current ratio1 9.40 7.45 15.20 8.98 9.36
Benchmarks
Current Ratio, Competitors2
AbbVie Inc. 0.96 0.79 0.84 3.18
Amgen Inc. 1.41 1.59 1.81 1.44
Bristol-Myers Squibb Co. 1.25 1.52 1.58 1.60
Danaher Corp. 1.89 1.43 1.86 5.19
Eli Lilly & Co. 1.05 1.23 1.40 1.16
Gilead Sciences Inc. 1.29 1.27 1.40 3.10
Johnson & Johnson 0.99 1.35 1.21 1.26
Merck & Co. Inc. 1.47 1.27 1.02 1.24
Moderna Inc. 2.73 1.76 1.43 7.89
Pfizer Inc. 1.22 1.40 1.35 0.88
Regeneron Pharmaceuticals Inc. 5.06 3.56 3.63 3.67
Thermo Fisher Scientific Inc. 1.48 1.50 2.13 1.92
Current Ratio, Sector
Pharmaceuticals, Biotechnology & Life Sciences 1.29 1.35 1.35 1.66
Current Ratio, Industry
Health Care 1.16 1.21 1.21 1.34

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Current ratio = Current assets ÷ Current liabilities
= 795,186 ÷ 84,617 = 9.40

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Cytokinetics Inc. current ratio deteriorated from 2020 to 2021 but then slightly improved from 2021 to 2022.

Quick Ratio

Cytokinetics Inc., quick ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in thousands)
Cash and cash equivalents 65,582 112,666 82,985 36,433 42,256
Short-term investments 716,995 358,972 381,075 188,679 156,475
Accounts receivable 147 51,819 4,420 5,163 2,231
Total quick assets 782,724 523,457 468,480 230,275 200,962
 
Current liabilities 84,617 71,860 31,199 26,023 22,194
Liquidity Ratio
Quick ratio1 9.25 7.28 15.02 8.85 9.05
Benchmarks
Quick Ratio, Competitors2
AbbVie Inc. 0.69 0.56 0.60 2.91
Amgen Inc. 0.95 1.06 1.30 1.01
Bristol-Myers Squibb Co. 0.87 1.20 1.28 1.26
Danaher Corp. 1.30 0.89 1.36 4.68
Eli Lilly & Co. 0.63 0.80 0.85 0.68
Gilead Sciences Inc. 0.99 0.95 1.08 2.86
Johnson & Johnson 0.71 1.04 0.91 0.94
Merck & Co. Inc. 0.93 0.73 0.58 0.78
Moderna Inc. 2.29 1.52 1.37 7.74
Pfizer Inc. 0.80 1.00 0.78 0.50
Regeneron Pharmaceuticals Inc. 4.16 2.98 2.86 2.81
Thermo Fisher Scientific Inc. 1.06 1.00 1.63 1.19
Quick Ratio, Sector
Pharmaceuticals, Biotechnology & Life Sciences 0.90 0.97 0.96 1.27
Quick Ratio, Industry
Health Care 0.86 0.90 0.90 1.00

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 782,724 ÷ 84,617 = 9.25

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Cytokinetics Inc. quick ratio deteriorated from 2020 to 2021 but then slightly improved from 2021 to 2022.

Cash Ratio

Cytokinetics Inc., cash ratio calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in thousands)
Cash and cash equivalents 65,582 112,666 82,985 36,433 42,256
Short-term investments 716,995 358,972 381,075 188,679 156,475
Total cash assets 782,577 471,638 464,060 225,112 198,731
 
Current liabilities 84,617 71,860 31,199 26,023 22,194
Liquidity Ratio
Cash ratio1 9.25 6.56 14.87 8.65 8.95
Benchmarks
Cash Ratio, Competitors2
AbbVie Inc. 0.31 0.28 0.30 2.56
Amgen Inc. 0.59 0.66 0.91 0.69
Bristol-Myers Squibb Co. 0.42 0.78 0.83 0.84
Danaher Corp. 0.71 0.32 0.82 4.04
Eli Lilly & Co. 0.13 0.26 0.29 0.21
Gilead Sciences Inc. 0.57 0.56 0.65 2.50
Johnson & Johnson 0.42 0.70 0.59 0.54
Merck & Co. Inc. 0.54 0.34 0.30 0.47
Moderna Inc. 2.01 1.18 1.05 7.71
Pfizer Inc. 0.54 0.73 0.47 0.26
Regeneron Pharmaceuticals Inc. 2.46 1.45 1.33 1.53
Thermo Fisher Scientific Inc. 0.50 0.33 1.00 0.39
Cash Ratio, Sector
Pharmaceuticals, Biotechnology & Life Sciences 0.51 0.58 0.57 0.89
Cash Ratio, Industry
Health Care 0.48 0.52 0.53 0.64

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 782,577 ÷ 84,617 = 9.25

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Cytokinetics Inc. cash ratio deteriorated from 2020 to 2021 but then slightly improved from 2021 to 2022.